KA
Kabeer Aziz
Partner at Adjuvant Capital
New York, New York
Overview
Kabeer Aziz is a Co-founder and Partner at Adjuvant Capital in New York, with a background in investment and finance, having worked at Global Health Investment Fund and Metalmark Capital. He has successfully invested in companies like Minervax, LimmaTech Biologics, and Pulmocide, contributing to the growth of the healthcare and biotech sectors.
Aziz's career highlights include his role as a Partner at Adjuvant Capital, where he focuses on investing in various sectors such as diagnostics, medical devices, pharmaceuticals, and biotech, and his previous experience at Global Health Investment Fund, Metalmark Capital, and Greenhill & Co. as an Analyst.
Work Experience
Partner
2018 - Current
Leading life sciences investment fund focused on global public health Board of Directors: AN2 Therapeutics, MinervaX, Pulmocide, Quantoom Biosciences, Frontier Nutrition Board Observer: YS Biopharma (2020-2022), Themis (2018-2020)
Adjuvant Capital is a life sciences investment firm focused on global health.
Senior Associate
2015 - 2018
Impact investing to finance global health research & development
Associate
2013 - 2015
Private / Growth Equity (Healthcare)
Analyst
2010 - 2013
Mergers & Acquisitions (Pharma and MedTech)
Greenhill & Co is an investment bank providing financial advices.
Raised $20,000,000.00.